← Back to Reports

Insperity Inc (NSP) – J Capital Research (The Equity Dispatch)

J Capital Research questions Insperity's 2026 profit guidance, HRScale accounting, dividend coverage, and borrowing-driven cash gains.

Insperity projects 2026 profit to rise by around 56%, the midpoint of a wide range of adjusted EBITDA outcomes, a forecast that has helped push NSP shares up 84% over the past six months.

The company is pinning that recovery on a new HRScale platform and cost cutting, but J Capital Research says the guidance is subject to considerable uncertainty, pointing to a GAAP rule allowing extra profit recognition and to premium increases that could offset savings on health claims.

Ticker: NSP (Insperity Inc)
Research Firm: J Capital Research (The Equity Dispatch)
Report URL: https://jcapitalresearch.substack.com/p/insperity-inc-nsp?ref=shortreport.fyi
Report date: 2026-10-01
Position Disclosure: Not stated in the free preview.

Free preview only: This post is based solely on the free preview of this report by J Capital Research (The Equity Dispatch). The full report is available to paid subscribers only. All research and analysis credit belongs to J Capital Research (The Equity Dispatch).

Read the full report from J Capital Research (The Equity Dispatch) →


Thesis

J Capital Research argues that Insperity's projected 2026 profit recovery and recent share rally rest on uncertain footing, from HRScale's accounting setup to a cash flow gap that has not covered the dividend.

  • HRScale accounting setup: NSP appears to be using a US GAAP rule that lets it generate extra profit by anticipating that some historically expensed operating costs will in future be capitalized, launching HRScale with only a small number of "Beta" clients.
  • Premium cost offset: Insperity is offloading volatility in health claims, but that cost cutting may be met by higher premiums to pay for the reduced volatility.
  • 2026 profit guidance: NSP projects 2026 profit to rise by around 56%, the midpoint of a wide range of adjusted EBITDA outcomes.
  • Dividend cash shortfall: The company has not generated enough operating cash flow to fund both capital expenditures and its dividend on a cumulative basis since end 2023.
  • Borrowed cash boost: Insperity's "adjusted cash position" rose in Q2 2026, but much of that extra cash represented proceeds from further borrowing.

"We are skeptical. Meanwhile, the company has also not generated enough operating cash flow to fund both capital expenditures and its dividend on a cumulative basis since end 2023."

— J Capital Research


FAQs

What does NSP's 2026 guidance project?

Insperity projects 2026 profit to rise by around 56%, the midpoint of a wide range of adjusted EBITDA outcomes. That projection has helped drive NSP shares up 84% over the past six months.

What is Insperity Inc.'s HRScale platform?

HRScale is a new offering Insperity is counting on, alongside cost cutting, to improve its financial results. J Capital Research notes it has launched with only a very small number of "Beta" clients.

What does J Capital Research say about Insperity's guidance?

J Capital Research says the 2026 profit guidance is subject to considerable uncertainty. It points to a GAAP rule that lets Insperity anticipate capitalizing costs historically expensed, and to the risk that health claim cost cuts will be offset by higher premiums.

Has Insperity's cash flow covered its dividend?

No. According to J Capital Research, the company has not generated enough operating cash flow to fund both capital expenditures and its dividend on a cumulative basis since end 2023, and much of the extra cash behind the rise in its Q2 2026 "adjusted cash position" came from further borrowing.


The full report is for paid subscribers. Read it from J Capital Research (The Equity Dispatch) at https://jcapitalresearch.substack.com/p/insperity-inc-nsp.


Disclaimer: This summary is not primary research and does not constitute investment advice. It is a brief overview of a detailed equity research report authored by the firm, organization, or source referenced in this article or at https://jcapitalresearch.substack.com/p/insperity-inc-nsp, which contains extensive evidence, regulatory filings, and analysis; readers are encouraged to review the full report there for a comprehensive understanding. The content provided in this publication is not authored or originated by us — we act solely as a distributor and do not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of the information presented. This publication is for informational purposes only and should not be construed as legal, business, investment, or tax advice. Always conduct independent due diligence and consult qualified professionals before making any decisions based on the information contained herein. We disclaim all liability for any loss or damage arising from reliance on third-party content, and the views expressed are solely those of the respective source and do not necessarily reflect our own.